Trials / Unknown
UnknownNCT04398771
To Evaluate Safety and Effectiveness of RovatitanTab.
A Multicenter, Single-arm, Prospective, Observational Study to Evaluate the Safety and Effectiveness of a Fixed-dose Combination Containing Valsartan and Rosuvastatin (Rovatitan® Tablet) in Patient With Hypertension and Hypercholesterolemia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- LG Chem · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and effectiveness of a fixed-dose combination containing valsartan and rosuvastatin (Rovatitan® Tablet) in patient with hypertension and hypercholesterolemia
Detailed description
* Effectiveness: the ratio of patients who reach target BP or LDL-cholesterol * Safety: we will collect safety data
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin/Valsartan | Rovatitan QD for 12 weeks |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2022-01-31
- Completion
- 2022-05-31
- First posted
- 2020-05-21
- Last updated
- 2020-05-21
Source: ClinicalTrials.gov record NCT04398771. Inclusion in this directory is not an endorsement.